FDA Issues Warning for Invokana Due to Drug’s Doubling Risk of Amputation

People across the nation who suffer from Type 2 Diabetes will likely receive a prescription from their treating physician for Invokana, Invokamet, or Invokamet XR to manage the disease. All of these drugs are SGLT2 inhibitors. In other words, they work to lower a patient’;s blood sugars. In fact, Invokana was the first prescription drug…

We all know it is wise to shop around for the best price when purchasing prescription drugs, but a Consumer Reports (CR) investigation shows just how widely prices can vary, even in the same zip code. In a secret shopper investigation, CR researchers called more than 150 pharmacies in six regions of the country to…

SGLT2 inhibitors — including Invokana — are a group of pharmaceutical drugs that are approved by the U.S. Food & Drug Administration (FDA) to treat patients who have Type 2 diabetes. The agency has warned, however, that SGLT2 inhibitors may lead to serious medical conditions. Some risks include diabetic ketoacidosis (DKA), increased bone breaks, kidney…

You might want to think twice before taking medical advice from Larry the Cable Guy. Larry tells you to take “One pill every morning” of Prilosec OTC (over-the-counter) medication to treat your frequent heartburn by decreasing the amount of acid in the stomach. Go ahead and eat that greasy plate of ribs. We are looking…

It’s a good idea to ask questions about supplements. After all, the U.S. Food and Drug Administration does not regulate the industry other than to clamp down on outrageous claims of muscle strength, sexual enhancement or heart health. Brain boosters are the latest type of supplement that promise to keep your brain agile into your…

The CEO of Mylan Pharmaceuticals has become the latest poster woman for corporate greed—the kind of publicity that no one wants. This fierce consumer backlash was directed at Heather Bresch after her company, Mylan, bumped the price of its lifesaving EpiPen from $124 to over $600. That’s a 400 percent jump in just seven years….